Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
83 studies found for:    Open Studies | "Lacrimal Apparatus Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Lacrimal Apparatus Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa
Conditions: Corneal Disease;   Blepharitis;   Lacrimal Apparatus Diseases
Interventions: Device: Handheld IVCM Vivascope 3000 (Caliber/Mavig) anesthesic eyedrop : oxybuprocaïne Thea 1,6 mg/0,4 ml;   Device: Multifluorescence IVCM vivascope 1500 ML (Caliber/Mavig);   Procedure: microangiography
2 Recruiting Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients
Conditions: Epiphora;   Conjunctivitis
Interventions: Device: Perforated Punctal plugs;   Procedure: Crawford tube insertion;   Device: Crawford lacrimal tube
3 Recruiting Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children
Condition: Lacrimal Duct Obstruction
Intervention: Procedure: "pushed" mono-canaliculonasal intubation
4 Recruiting A Comparative Study of Two Endoscopic Operations for Lacrimal Duct Obstruction
Condition: Lacrimal Duct Obstruction
Interventions: Procedure: Recessive Spherical Headed Silicone Intubation;   Procedure: Dacryocystorhinostomy
5 Recruiting Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
6 Recruiting Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
7 Recruiting Corneal Protect Used During Cataract Surgery
Condition: Cataract
Interventions: Device: Hydroxypropyl ethylcellulose (HPMC) 2% gel;   Device: BSS
8 Recruiting Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
Conditions: Dry Eye Syndrome;   Keratoconjunctivitis Sicca
Intervention: Device: Oculeve Intranasal Neurostimulator
9 Not yet recruiting Three Dimension Tomography of Eye Structures by White Light Imaging Device
Conditions: Healthy Subjects;   Moderate to Severe Keratoconjunctivitis Sicca (KCS);   Dry Eye Syndrome (DES)
Intervention: Device: None invasive imaging of the tear film (AdOM)
10 Recruiting Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Condition: Dry Eye
Interventions: Drug: OmegaD;   Drug: Placebo
11 Recruiting Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
12 Recruiting Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Tear Deficient Dry Eye Disease.
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
13 Not yet recruiting A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease
Condition: Dry Eye Disease
Intervention: Drug: ISV 101
14 Recruiting Evaluation of Factors Affecting the Tear-film Lipid Layer Thickness
Condition: Dry Eye Syndrome
Intervention:
15 Recruiting Point of Care Testing of Inflammatory Markers in Tears
Condition: Dry Eye Syndrome
Interventions: Other: Eye inflammation;   Other: Without eye inflammation
16 Recruiting Ocular Surface Microbiome
Condition: Dry Eye Syndromes
Intervention:
17 Recruiting The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
Conditions: Thyroid-associated Ophthalmopathy;   Dry Eye Syndrome
Interventions: Drug: Methylprednisolone;   Drug: Esomeprazole
18 Recruiting Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye Syndrome
Condition: Dry Eye Syndromes
Interventions: Device: Thealoz Duo eye drops and Thealoz Duo gel;   Device: Thealoz Duo gel
19 Not yet recruiting A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye
Condition: Dry Eye
Interventions: Device: CBL-101 Eye Drops;   Device: Vismed® Multi
20 Recruiting Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
Condition: Dry Eye Syndrome
Interventions: Drug: RGN-259;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.